1083 related articles for article (PubMed ID: 19232732)
1. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab.
Sayanagi K; Sharma S; Yamamoto T; Kaiser PK
Ophthalmology; 2009 May; 116(5):947-55. PubMed ID: 19232732
[TBL] [Abstract][Full Text] [Related]
2. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization.
Khurana RN; Dupas B; Bressler NM
Ophthalmology; 2010 Jul; 117(7):1376-80. PubMed ID: 20452027
[TBL] [Abstract][Full Text] [Related]
3. Spectral-domain versus time domain optical coherence tomography before and after ranibizumab for age-related macular degeneration.
Querques G; Forte R; Berboucha E; Martinelli D; Coscas G; Soubrane G; Souied EH
Ophthalmic Res; 2011; 46(3):152-9. PubMed ID: 21389740
[TBL] [Abstract][Full Text] [Related]
4. Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements.
Taban M; Sharma S; Williams DR; Waheed N; Kaiser PK
Ophthalmology; 2009 May; 116(5):964-70. PubMed ID: 19410954
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
[TBL] [Abstract][Full Text] [Related]
6. In vivo three-dimensional imaging of neovascular age-related macular degeneration using optical frequency domain imaging at 1050 nm.
de Bruin DM; Burnes DL; Loewenstein J; Chen Y; Chang S; Chen TC; Esmaili DD; de Boer JF
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4545-52. PubMed ID: 18390638
[TBL] [Abstract][Full Text] [Related]
7. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Fung AE; Lalwani GA; Rosenfeld PJ; Dubovy SR; Michels S; Feuer WJ; Puliafito CA; Davis JL; Flynn HW; Esquiabro M
Am J Ophthalmol; 2007 Apr; 143(4):566-83. PubMed ID: 17386270
[TBL] [Abstract][Full Text] [Related]
8. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Kaiser PK; Blodi BA; Shapiro H; Acharya NR;
Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
[TBL] [Abstract][Full Text] [Related]
9. Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy.
Golbaz I; Ahlers C; Stock G; Schütze C; Schriefl S; Schlanitz F; Simader C; Prünte C; Schmidt-Erfurth UM
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1599-605. PubMed ID: 21051733
[TBL] [Abstract][Full Text] [Related]
10. Effects on choroidal neovascularization after anti-VEGF Upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomography.
Framme C; Panagakis G; Birngruber R
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1671-6. PubMed ID: 19875667
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration.
Coscas F; Coscas G; Souied E; Tick S; Soubrane G
Am J Ophthalmol; 2007 Oct; 144(4):592-9. PubMed ID: 17698019
[TBL] [Abstract][Full Text] [Related]
12. Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration.
Salinas-Alamán A; García-Layana A; Maldonado MJ; Sainz-Gómez C; Alvárez-Vidal A
Am J Ophthalmol; 2005 Jul; 140(1):23-8. PubMed ID: 15922284
[TBL] [Abstract][Full Text] [Related]
13. Comparison of spectral-domain and time-domain optical coherence tomography in the detection of neovascular age-related macular degeneration activity.
Major JC; Wykoff CC; Mariani AF; Chen E; Croft DE; Brown DM
Retina; 2014 Jan; 34(1):48-54. PubMed ID: 23764967
[TBL] [Abstract][Full Text] [Related]
14. Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration.
Sayanagi K; Sharma S; Kaiser PK
Br J Ophthalmol; 2009 May; 93(5):622-6. PubMed ID: 19208677
[TBL] [Abstract][Full Text] [Related]
15. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration.
Malamos P; Sacu S; Georgopoulos M; Kiss C; Pruente C; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4926-33. PubMed ID: 19494200
[TBL] [Abstract][Full Text] [Related]
16. Visualization of sub-retinal pigment epithelium morphologies of exudative macular diseases by high-penetration optical coherence tomography.
Yasuno Y; Miura M; Kawana K; Makita S; Sato M; Okamoto F; Yamanari M; Iwasaki T; Yatagai T; Oshika T
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):405-13. PubMed ID: 18676629
[TBL] [Abstract][Full Text] [Related]
17. Spectral-domain optical coherence tomography with multiple B-scan averaging for enhanced imaging of retinal diseases.
Sakamoto A; Hangai M; Yoshimura N
Ophthalmology; 2008 Jun; 115(6):1071-1078.e7. PubMed ID: 18061270
[TBL] [Abstract][Full Text] [Related]
18. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
[TBL] [Abstract][Full Text] [Related]
19. Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease.
Ahlers C; Golbaz I; Einwallner E; Dunavölgyi R; Malamos P; Stock G; Pruente C; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3417-24. PubMed ID: 19168899
[TBL] [Abstract][Full Text] [Related]
20. Comparison of retinal thickness measurements between three-dimensional and radial scans on spectral-domain optical coherence tomography.
Sayanagi K; Sharma S; Kaiser PK
Am J Ophthalmol; 2009 Sep; 148(3):431-8. PubMed ID: 19493524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
